GENEWIZ offers CLIA-compliant whole genome sequencing as a comprehensive analysis of the entire genome to uncover mutations in coding and non-coding regions, including structural and copy number variants.
Our CLIA-compliant next generation sequencing services provide sensitive and unbiased detection of genetic variants. These assays enable clinical researchers to answer focused biological questions using genome-scale information, fueling the advancement of precision medicine and biomarker discovery.
We also offer RUO whole genome sequencing for your non-clinical needs.
Submit DNA or blood sample
Sequencing on the Illumina® NovaSeq™ 6000
Receive raw data files and variant report
|Service Level*||Data & Report
(FASTQ, BAM & VCF)
|QA Oversight||Lab Director Signature|
Included | Not Available
*All service levels are performed by CLIA-trained personnel in a CLIA-certified lab with CLIA-qualified equipment.
A biopharma company required a partner for clinical trial support, with an immediate need for development and validation of a biomarker assay using next generation sequencing with a quick turnaround time. Read the case study to learn how this company was able to streamline clinical testing and accelerate the timeline of its phase 1/2 study.
Our PCR-free WGS workflow empowers clinical researchers to detect disease-related genetic variants in both coding and non-coding regions. In addition, the sequencing data can be used to identify novel variants of unknown significance and reanalyzed once additional disease-related information becomes available.